期刊文献+

Low eradication rate of Helicobacterpyloriwith triple 7-14 days and quadriple therapy in Turkey 被引量:4

Low eradication rate of Helicobacterpyloriwith triple 7-14 days and quadriple therapy in Turkey
在线阅读 下载PDF
导出
摘要 AIM:The eradication rate of Helicobacter pylori (H pylori) shows variation among countries and regimens of treatment. We aimed to study the eradication rates of different regimens in our region and some factors affecting the rate of eradication. METHODS:One hundred and sixty-four H pylori positive patients (68 males,96 females;mean age:48±12 years) with duodenal or gastric ulcer without a smoking history were included in the study.The patients were divided into three groups according to the treatment regimens.Omeprazole 20mg,clarithromycin 500mg,amoxicillin 1g were given twice daily for 1 week (Group Ⅰ) and 2 weeks (Group Ⅱ). Patients in Group Ⅲ received bismuth subsitrate 300mg, tetracyline 500mg and metronidazole 500mg four times daily in addition to Omeprazole 20mg twice daily.Two biopsies each before and after treatment were obtained from antrum and corpus,and histopathologically evaluated. Eradication was assumed to be successful if no H pylorus was detected from four biopsy specimens taken after treatment.The effects of factors like age,sex,H pylori density on antrum and corpus before treatment,the total H pylori density,and the inflammation scores on the rate of H pylori eradication were evaluated. RESULTS:The overall eradication rate was 42%.The rates in groups Ⅱ and Ⅲ were statistically higher than that in group Ⅰ (P<0.05).The rates of eradication were 24.5%, 40.7% and 61.5% in groups Ⅰ,Ⅱ and Ⅲ,respectively.The eradication rate was negatively related to either corpus H pylori density or total H pylori density (P<0.05).The median age was older in the group in which the eradication failed in comparison to that with successful eradication (55 yr vs 39 yr,P<0.001).No correlation between sex and H pylori eradication was found. CONCLUSION:Our rates of eradication were significantly lower when compared to those reported in literature.We believe that advanced age and high H pylori density are negative predictive factors for the rate of H pylori eradication. AIM:The eradication rate of Helicobacter pylori (H pylon) shows variation among countries and regimens of treatment.We aimed to study the eradication rates of different regimens in our region and some factors affecting the rate of eradication.METHODS:One hundred and sixty-four Hpylori positivepatients (68 males, 96 females; mean age:48±12 years)with duodenal or gastric ulcer without a smoking history were included in the study. The patients were divided into three groups according to the treatment regimens. Omeprazole 20mg, clarithromycin 500mg, amoxicillin 1g were given twice daily for 1 week (Group I) and 2 weeks (Group Ⅱ).Patients in Group Ⅲ received bismuth subsitrate 300mg,tetracyline 500 mg and metronidazole 500mg four times daily in addition to Omeprazole 20mg twice daily.Two biopsies each before and after treatment were obtained from antrum and corpus, and histopathologically evaluated.Eradication was assumed to be successful if no Hpylorus was detected from four biopsy specimens taken after treatment. The effects of factors like age, sex, Hpyloridensity on antrum and corpus before treatment, the total Hpylori density, and the inflammation scores on the rate of Hpylori eradication were evaluated.RESULTS:The overall eradication rate was 42%. The rates in groups Ⅱ and Ⅲ were statistically higher than that in group I (P<0.05). The rates of eradication were 24.5%,40.7% and 61.5% in groups Ⅰ, Ⅱ and Ⅲ, respectively. The eradication rate was negatively related to either corpus Hpylori density or total Hpyloridensity (P<0.05).The median age was older in the group in which the eradication failed in comparison to that with successful eradication (55yr vs 39yr, P<0.001). No correlation between sex and Hpylori eradication was found.CONCLUSION: Our rates of eradication were significantly lower when compared to those reported in literature.We believe that advanced age and high Hpyloridensity are negative predictive factors for the rate of Hpylorieradication.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第5期668-671,共4页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献35

  • 1Ikeda S, Tamamuro T, Hamashima C, Asaka M. Evaluation of the cost-effectiveness of Helicobacter pylori eradication triple therapy vs conventional therapy for ulcers in Japan. Aliment Pharmacol Ther 2001; 15:1777-1785.
  • 2Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R,Axon A, Graham DY, Tytgat G. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Revort. Aliment Pharmacol Ther 2002:16: 167-1R~.
  • 3Marzio L, Cellini L, Angelucci D. Triple therapy for 7 days vs.triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacter pylori infection.A double blind placebo controlled trial. Dig Liver Dis 2003; 35:20-23.
  • 4Leodolter A, Kulig M, Brasch H, Meyer-Sabellek W, Willich SN,Malfertheiner P. A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori -associated gastric or duodenal ulcer. Aliment Pharmacol Ther 2001; 15: 1949-1958.
  • 5Tytgat GN. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence.Aliment Pharmacol Ther 1994; 8:359-368.
  • 6Bhasin DK, Sharma BC, Ray P, Pathak CM, Singh K. Comparison of Seven and Fourteen Days of Lansaprazole, Claritromycin and amoxicillin Therapy for Eradication of Helicobacter pylori:AReport from India. Helicobacter 2000; 5:84-87.
  • 7Dixon MF, Genta RM, Yardley JH, Correa P. Classification and Grading of Gastritis. The Updated Sydney system. Am J Surg Pathol 1996; 20: 1161-1181.
  • 8Yang HB, Sheu BS, Su IJ, Chien CH, Lin XZ. Clinical Application of Gastric Histology to Monitor Treatment of Dual Therapy in H pylori Eradication. Dig Dis Sci 1997; 42:1835-1840.
  • 9Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1:1273-1275.
  • 10World Health Organization. International agency for research on cancer. Ynfection with Helicobacter pylori. Schistosomes, Liver flukes and Helicobacter pylori. Lyon: IARC 1994:172-202.

同被引文献48

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部